Meeting

State-of-the-Art Clinical Symposium

Date:

April 29–30

Location:

Orlando, FL

Program Information

During the State-of-the-Art Clinical Symposium (SOTA), key opinion leaders will deliver a range of content in areas such as therapeutic developments, recent research findings, and scientific advances, in an environment conducive to dialogue and networking.

SOTA is one of the meetings being held during the ACR Education Exchange 2023.

Target Audience
This activity is designed for rheumatologists (physicians) in clinical care and/or research, fellows in training, division directors, program directors, assistant program directors, physician assistants, nurse practitioners, pharmacists, nurses, and epidemiologists.

Learning Objectives
Upon completion of this program, participants should be able to:

  • Discuss the most up-to-date evidence-based treatment approaches in the management of rheumatic diseases
  • Identify and describe recent scientific and clinical advances regarding the pathogenesis of rheumatology

Accreditation
This activity has been approved for AMA PRA Category 1 Credit™.

Registration and housing information and a detailed program will be available in February.

See information from the 2022 meeting in the 2022 State-of-the-Art Clinical Symposium tab below.

Program Schedule

Coming soon

Registration Fees

Coming soon

Syllabi

Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.

CME and MOC Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this Other activity (Live) for a maximum of (to be announced) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to (to be announced) Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and (to be announced) MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC credit.

By completing this activity you provide the ACR permission to share completion data with the ACCME and the certifying board(s).

ABIM CME MOC Certified Part 2 ABP MOC

Faculty and Disclosures

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

Nature of Financial Relationships
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial relationships with ineligible companies any financial or other relationship(s) with an ineligible company including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speaker's bureau, symposia, and expert witness
  7. Independent contractor
  8. Ownership interest
  9. Royalties
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Other financial or material support

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

View ACR's ACCME disclosure practices

See 2022 disclosures in 2022 meeting section below.

Corporate Support

The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives. See current supporters, guidelines, and benefits of supporting the ACR.

COVID-19 Policies

We thank you for your continued cooperation and applaud individuals' efforts to prevent the spread of infectious agents. Prior to attending an ACR face-to-face event, please be sure to review the current ACR requirements for meeting entry and attendance as these vary according to local requirements and may have changed since your last meeting. Individuals with symptoms or known infections are requested to stay home and not participate in face-to-face ACR gatherings.

2022 State-of-the-Art Clinical Symposium

See information from the 2022 State-of-the-Art Clinical Symposium

CME: 11.50    MOC: 11.50

Target Audience
Rheumatologists, physicians, and health care providers who care for patients with rheumatic diseases, and those interested or engaged in rheumatology research.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the most up-to-date evidence-based treatment approaches in the management of rheumatic diseases
  • Identify and describe recent scientific and clinical advances regarding the pathogenesis of rheumatic diseases

The deadline to claim CME credit/MOC points is April 28, 2023 at 11:59 PM ET.

View ACR's ACCME disclosure practices

View Education Exchange Disclosures

Educational grant support for this activity has been provided by Janssen, Pfizer, and AbbVie.

Contact Info / Inquiries

American College of Rheumatology
education@rheumatology.org
404-633-3777, ext. 381

Registration Support Center
ACRSupport@cmrus.com
800-636-4766 (US & Canada)
415-979-2265 (International)
Fax: 415-293-5231

© 2023 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us